Terms of reference

1. To explore what pharmacogenetics offers now and is likely to offer in the near future;

In particular to examine the effect of pharmacogenetics on:

a) the design of medicines, the promotion of efficacy and safety in the administration of medicines to individuals;
b) the conduct of clinical trials in the context of pharmaceutical research and development;
c) clinical practice.

2. To consider ethical issues specifically raised by pharmacogenetics;

In particular to examine the following areas:

a) consent, privacy and confidentiality;
b) the management of information about the likelihood of response to treatment;
c) the implications of differentiating individuals into groups based on the likelihodd of response to treatment.

3. To consider the implications for the provision of healthcare.

Previous work

Contact us

Nuffield Council on Bioethics
28 Bedford Square
London, WC1B 3JS

Tel: +44 (0)20 7681 9619

General enquiries:

Press enquiries:

Sign up for e-news


Explore by topic